Accordingly, in our erlotinib-resistant NSCLC cell lines, both SATB2-AS1 (plum4 module) and SATB2 (deeppink module) are upregulated, suggesting a similar positive regulation of the coding gene by the lncRNA. The gene discussed is SATB2; the disease is non-small cell lung carcinoma.